Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
The Medicare program has released the list of 10 drugs covered under Medicare's Part D price negotiations.News Article updated on 08/31/2023
-
CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children
In November 2023, CDC published new recommendations for hepatitis C testing for perinatally exposed infants and children.News Article updated on 12/19/2023 -
Funding Opportunity: RWHAP Implementation for HIV Clinical Quality Improvement (HRSA-24-072)
This HRSA HIV/AIDS Bureau pre-application webinar was for the Notice of Funding Opportunity, Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical Quality Improvement (HRSA-24-072).Resource updated 01/29/2024
-
Konprann Doub Elijibilite: Yon Gid pou Moun ki Gen Asirans Medicare ak Medicaid
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
-
Comprender la Doble Elegibilidad: Una guía para personas con VIH sobre la cobertura de Medicare y Medicaid
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024
-
Update on Mpox Vaccination Rates
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024 -
Infographic on Ryan White HIV/AIDS Program, 2022 Data
The HRSA HIV/AIDS Bureau's Infographic summarizes data on clients served and health outcomes among people getting HIV-related medical care from the Ryan White HIV/AIDS ProgramNews Article updated on 01/17/2024 -
Tool for People with HIV: Medicare-Medicaid Dual Eligibility
You asked, we listened: New resource for people with HIV on Medicare-Medicaid dual eligibility now available.News Article updated on 01/22/2024 -
RWHAP Part A Recipient Fiscal TA
Review of legislative and programmatic requirements related to procurement, contracting, budgeting, accounting, invoicing, payment, and reporting. Also covers how to use a self-assessment tool to test for compliance and shares compliance tips.Resource updated 03/12/2024
-
RWHAP Part C, D, and F Stakeholder Meeting - July 2023
Session covered program updates and recruiting/retaining staff.Resource updated 01/10/2024
-
Integrated HIV Prevention and Care Plan Summary Statement Overview
HRSA/CDC review of the HIV Integrated Prevention and Care Plan Summary Statement, CY 2022-2026.Resource updated 08/03/2023
-
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
A Selection of Community Engagement Tools
Access these National Academy of Medicine and RWHAP consumer engagement tools.News Article updated on 06/23/2023 -
HRSA Launches HIV Awareness Initiative
The HRSA CHANGE initiative seeks to enhance awareness in African American communities about HIV and effective treatments.Blog updated 08/09/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Funding Opportunity: RWHAP Part F Regional AETC Program (HRSA-24-059)
This HRSA HIV/AIDS Bureau pre-application technical assistance webinar was for the Ryan White HIV/AIDS Program (RWHAP) Part F Regional AIDS Education and Training Centers (AETC) Program (HRSA-24-059).Resource updated 12/28/2023
-
Funding Opportunity: RWHAP Part F National AETC Support Center Technical Assistance (HRSA-24-099)
This HRSA HIV/AIDS Bureau pre-application technical assistance webinar was for Ryan White HIV/AIDS Program Part F National AETC Support Center (HRSA-24-099).Resource updated 12/27/2023
-
Understanding Dual Eligibility: A Guide for People with HIV About Medicare and Medicaid Coverage
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
-
National HIV/AIDS Strategy 2023 Interim Action Report Released
The White House released the National HIV/AIDS Strategy 2023 Interim Action Report (PDF, 222KB) on December 1.News Article updated on 12/05/2023 -
DCHAP RWHAP Part D Virtual Symposium - 2023
Forum for sharing of clinical, social, and structural topics of interest to the Ryan White HIV/AIDS Program's (RWHAP) Part D, Women, Infants, Children, and Youth.Resource updated 12/13/2023